SCHEMBL34469602

SCHEMBL34469602

COC(=O)c1cc(-c2ccc(Cl)cc2F)n(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.46
▸ CYP2C19 P33261 3/20 0.46
▸ MAPT P10636 4/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ ALPL P05186 2/20 0.40
▸ ABL1 P00519 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ BRD4 O60885 1/20 0.38
▸ BRD2 P25440 1/20 0.38
▸ BRD3 Q15059 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34469989 0.86 ALPL (0.50) MAPTMEN1KMT2AALPLLMNA
SCHEMBL34469812 0.85 TDP1 (0.42) MAPTALPLLMNAHSD17B10TSHR
SCHEMBL34470254 0.85 KMO (0.44) CYP1A2CYP2C19MAPTMEN1KMT2A
SCHEMBL34470235 0.82 ALPL (0.47) CYP1A2CYP2C19MAPTCASP3ALPL
SCHEMBL34469524 0.82 MDM4 (0.41) CYP1A2CYP2C19MAPTMEN1KMT2A
SCHEMBL34470148 0.81 ALDH1A1 (0.41) MAPTMEN1KMT2AALPLLMNA
SCHEMBL34469830 0.79 CYP1A2 (0.48) CYP1A2CYP2C19MAPTCASP3SENP7
SCHEMBL34469835 0.79 MAPT (0.49) CYP1A2CYP2C19MAPTMEN1KMT2A
SCHEMBL34470120 0.77 SCN9A (0.43) CYP1A2CYP2C19MAPTMEN1KMT2A
SCHEMBL30535501 0.77 S1PR1 (0.37) CYP1A2CYP2C19MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026090477-A1 HELICASE INHIBITORS AND USES THEREOF KIMIA THERAPEUTICS, INC. (US) 2026-04-30 — — WO disclosed
Send feedback